Combination of Cetuximab, Capecitabine, and Oxaliplatin With or Without Bevacizumab

ABSTRACT: The purpose of this study is to determine the objective response rate of patients with previously untreated metastatic colorectal cancer treated with the combination of cetuximab, capecitabine, and oxaliplatin with out without bevacizumab.

DISEASE(S): Colorectal Neoplasms,Cancer

PROVIDER: 2028571 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR